#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	756	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1401	40.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	462	464	ACG	73;74;74	A;C;G	73;73;73	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	756	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1401	40.7	0	.	p	.	0	T209S	NONSYN	625	627	ACT	1002	1004	TCT	47;47;47	T;C;T	47;46;46	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	2598	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1770	106.7	1	SNP	p	R234F	1	.	.	700	702	TTC	1060	1062	TTC	174;172;171	T;T;C	174;171;168	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	2598	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1770	106.7	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1360	1362	CGT	123;128;127	C;G;T	122;125;123	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	2598	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1770	106.7	0	HET	.	.	.	T999C	.	999	999	T	1359	1359	T	119	T,C	74,44	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	2598	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1770	106.7	0	HET	.	.	.	T180C	.	180	180	T	540	540	T	115	T,C	69,41	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	2598	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1770	106.7	0	HET	.	.	.	C261T	.	261	261	C	621	621	C	140	C,T	76,62	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1254	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1992	47.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1650	1652	AAA	32;31;31	A;A;A	30;30;30	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1640	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c4.ctg.1	1930	63.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1324	1326	GAA	89;88;87	G;A;A	88;87;87	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	436	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	1175	28.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	C990G	SNP	990	990	C	58	58	G	115	G	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	T1002A	SNP	1002	1002	T	70	70	A	121	A	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	A1004G	SNP	1004	1004	A	72	72	G	118	G	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	C1011T	SNP	1011	1011	C	79	79	T	110	T	110	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	C1023A	SNP	1023	1023	C	91	91	A	120	A	117	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	T1024A	SNP	1024	1024	T	92	92	A	121	A,T	116,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	T1041G	SNP	1041	1041	T	109	109	G	131	G	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c17.ctg.2	183	138.7	0	.	n	.	0	A1042T	SNP	1042	1042	A	110	110	T	131	T	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T50C	SNP	50	50	T	203	203	C	160	C	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	G74A	SNP	74	74	G	227	227	A	112	A	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	G81.	DEL	81	81	G	233	233	A	82	A	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	A83C	SNP	83	83	A	235	235	C	69	C	66	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T92G	SNP	92	92	T	244	244	G	43	G	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	C94.	DEL	94	94	C	245	245	T	42	T,C	34,8	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T97C	SNP	97	97	T	248	248	C	48	C	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T128C	SNP	128	128	T	279	279	C	71	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T135A	SNP	135	135	T	286	286	A	78	A	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	G139C	SNP	139	139	G	290	290	C	84	C	83	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	.	n	.	0	T142G	SNP	142	142	T	293	293	G	87	G	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	155	92.26	Pasteurella_multocida_16S.l15.c17.ctg.3	323	84.6	0	HET	.	.	.	A82G	.	82	82	A	234	234	A	71	A,G	57,12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	301	G,T	296,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	301	C	299	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	324	C	320	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	404	T,G,C	397,1,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	390	C	388	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	321	C	317	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	277	A	273	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	244	A	241	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	237	A	237	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	236	T	232	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	239	C	237	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	254	C	252	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	254	A	252	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	249	G	249	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	249	C	248	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	268	T	264	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	296	G	290	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	297	G	293	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	300	T	295	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	385	T	383	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	384	G	383	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	370	C	365	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	367	A	360	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	257	C	251	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	233	C	229	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	193	A	191	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	198	A	198	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	220	G	214	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	184	C	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	261	T	261	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	271	G	270	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	262	T	260	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.4	734	241.6	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	436	C	432	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	C990G	SNP	990	990	C	56	56	G	82	G	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	T1002A	SNP	1002	1002	T	68	68	A	87	A	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	A1003C	SNP	1003	1003	A	69	69	C	87	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	G1008C	SNP	1008	1008	G	74	74	C	88	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	C1011T	SNP	1011	1011	C	77	77	T	85	T	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	T1012C	SNP	1012	1012	T	78	78	C	89	C	89	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	C1023A	SNP	1023	1023	C	88	88	A	91	A	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	.1025G	INS	1025	1025	T	91	91	G	100	G	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	107	107	G	101	G	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	676	4476	Pasteurella_multocida_16S	1551	181	92.31	Pasteurella_multocida_16S.l15.c17.ctg.5	181	77.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	108	108	T	100	T	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1124	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1738	48.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	382	384	CGT	55;56;56	C;G;T	55;55;56	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1124	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1738	48.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1225	1227	GGC	71;71;72	G;G;C	69;71;72	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1820	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2167	63.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	253	255	AGC	46;46;50	A;G;C,A	45;45;49,1	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1820	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2167	63.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	655	657	CTA	54;54;55	C;T;A	53;54;55	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1820	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2167	63.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1174	1176	CAA	76;75;75	C;A;A	75;74;74	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1820	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2167	63.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1273	1275	GGT	101;101;101	G;G;T	101;101;99	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1820	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2167	63.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1843	1845	GTT	75;70;71	G;T;T	75;70;71	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	798	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1803	33.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	747	749	GAA	50;48;48	G;A;A	49;47;47	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	798	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1803	33.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	927	929	ACC	34;34;37	A;C;C	33;34;37	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	798	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1803	33.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1047	1049	ACT	24;24;24	A;C;T	24;22;24	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	798	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1803	33.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1437	1439	ATC	24;24;25	A;T;C	24;24;25	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1066	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1622	49.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	17	864	aad-	789	703	100.0	aad-.l15.c30.ctg.1	1135	56.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3062	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3568	64.6	0	.	p	.	0	T85I	NONSYN	253	255	ACC	545	547	ATC	70;71;72	A;T;C	69;70;72	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3062	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3568	64.6	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1937	1939	AGC	89;87;84	A,G;G;C	87,1;87;84	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3062	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3568	64.6	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2258	2260	AAG	54;52;52	A;A;G	53;51;52	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1108	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1896	43.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	485	487	GTC	34;33;34	G;T;C	34;33;34	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1108	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1896	43.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1226	1228	TGC	87;89;87	T;G;C	86;87;85	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	411	411	T	48	T	48	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	717	719	GAC	78;76;77	G;A;C	77;74;75	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	993	995	TTA	47;46;47	T;T;A	46;46;47	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2070	2072	AAT	76;76;76	A;A,T;T	76;75,1;76	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2184	2186	AGT	66;67;67	A;G;T	65;67;67	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2583	2585	GTG	52;53;52	G;T;G	51;49;52	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3252	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3663	66.5	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3138	3140	AAG	100;102;102	A;A;G	97;99;101	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	664	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1386	36.2	1	SNP	p	R45C	0	.	.	133	135	CGC	484	486	CGC	57;57;62	C;G;C	57;57;62	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	632	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1130	41.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	287	289	TTC	59;58;54	T;T;C	58;56;50	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	632	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1130	41.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	551	553	GGG	63;63;62	G;G;G	63;63;62	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	798	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1203	49.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	609	611	CTT	77;77;77	C;T;T	76;76;76	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2832	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3379	63.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2221	2223	GCA	81;83;83	G;C;A	80;82;81	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2832	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3379	63.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2482	2484	ACC	64;64;65	A;C;C	58;64;65	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2832	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3379	63.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2791	2793	GCC	89;90;92	G;C;C	89;90;92	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	539	541	GCT	42;42;43	G;C;T	42;42;42	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	659	661	GAG	37;38;41	G;A;G	37;37;39	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	695	697	TGC	50;49;46	T;G;C	49;47;46	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	878	880	GTT	57;60;60	G;T;T	57;59;60	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	1028	1030	CAC	67;67;66	C;A;C	66;67;66	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1313	1315	ATG	65;65;65	A;T;G	64;62;65	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1788	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2472	53.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2309	2311	CGC	58;56;57	C;G;C	57;54;54	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	806	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1293	46.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	960	962	ACC	39;39;39	A;C;C	39;39;39	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	806	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1293	46.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	972	974	TCG	45;44;48	T;C;G	45;44;47	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	696	baeR	723	723	97.79	baeR.l6.c30.ctg.1	1500	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	974	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1924	37.8	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1392	1394	AAA	22;22;22	A;A;A	22;22;21	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	974	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1924	37.8	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1404	1406	GAG	23;23;23	G;A;G	23;22;22	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	974	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1924	37.8	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1410	1412	CAC	24;26;26	C;A;C	23;24;24	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	974	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1924	37.8	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1464	1466	GAG	31;31;31	G;A;G	31;31;30	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
blaTem.manually_added_GQ983346_ADN79103.1_1_861	blaTem.manually_added_GQ983346_ADN79103.1_1_861	1	0	27	590	TEM_1+	861	861	100.0	TEM_1+.l15.c4.ctg.1	1266	34.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: GQ983346.1 Escherichia coli strain 1C plasmid beta-lactamase TEM-1 (blaTEM-1) gene, complete cds
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1272	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	2109	45.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	764	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1249	46.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	954	cysB	975	975	99.38	cysB.l6.c4.ctg.1	1626	44.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	506	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	1287	29.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	990	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1735	42.9	0	.	p	.	0	W42C	NONSYN	124	126	TGG	434	436	TGT	37;38;36	T;G;T	37;37;35	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	990	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1735	42.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	965	967	GTC	72;72;71	G;T,C;C	72;71,1;70	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	990	emrA	1173	1173	98.21	emrA.l15.c4.ctg.1	1735	42.9	0	.	p	.	0	G234A	NONSYN	700	702	GGG	1010	1012	GCG	63;62;60	G;C,G;G	61;60,1;58	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1456	emrB	1539	1539	99.81	emrB.l15.c17.ctg.1	2184	49.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1032	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1710	45.3	0	.	p	.	0	G209S	NONSYN	625	627	GGC	863	865	AGC	75;75;74	A;G;C	72;74;72	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	19	74	emrE_1	333	291	93.81	emrE_1.l15.c30.ctg.1	632	8.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	960	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1698	42.6	0	.	p	.	0	K176R	NONSYN	526	528	AAG	868	870	AGG	37;38;37	A;G;G	37;38;36	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	960	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1698	42.6	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1258	1260	GAC	46;44;44	G;A;C	46;44;44	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	628	emrR	531	531	100.0	emrR.l15.c17.ctg.1	1125	42.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1604	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2134	56.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	510	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1325	29.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	541	543	CTG	49;49;49	C;T;G	49;49;49	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	351	353	ATA	47;46;45	A;T;A,G	47;46;44,1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	363	365	GTA	52;54;53	G;T;A	52;54;53	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	516	518	ACG	55;55;55	A;C;G	55;55;55	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	579	581	GAA	51;51;50	G;A;A	51;51;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	618	620	GCT	45;45;44	G;C;T	45;45;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	636	638	GAT	47;48;48	G;A;T	47;48;48	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	723	725	TCA	42;44;44	T;C,G;A	41;42,1;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	852	854	CAG	40;40;40	C;A;G	40;40;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	990	992	GTT	33;32;31	G;T;T	33;32;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1146	1148	GAT	31;32;32	G;A;T	31;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1314	1316	AAT	21;22;22	A;A;T	21;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1335	1337	TTA	22;20;21	T;T;A	22;20;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1536	1538	AAA	36;36;36	A;A;A	36;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2271	2273	CAT	48;48;47	C;A;T	48;47;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2325	2327	CAT	39;37;38	C;A;T	39;36;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2343	2345	AGA	40;40;40	A;G;A	39;40;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2358	2360	AAT	50;50;51	A;A;T	50;50;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2505	2507	TCC	56;55;57	T;C;C	55;54;57	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2670	2672	ATT	56;59;58	A;T;T	55;59;58	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2691	2693	GAT	54;51;51	G;A;T	54;51;51	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2805	2807	GTT	55;55;56	G;T;T	55;55;56	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3090	3092	CAC	79;79;78	C;A;C	79;78;78	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2850	evgS	3594	3594	97.52	evgS.l6.c17.ctg.1	4148	51.6	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	3828	3830	AAC	34;34;34	A;A;C	32;34;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	894	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1540	43.6	1	SNP	p	P64R	0	.	.	190	192	CCA	540	542	CCA	78;79;80	C;C,T;A	76;76,1;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	894	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1540	43.6	1	SNP	p	P64H	0	.	.	190	192	CCA	540	542	CCA	78;79;80	C;C,T;A	76;76,1;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	894	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1540	43.6	1	SNP	p	P64A	0	.	.	190	192	CCA	540	542	CCA	78;79;80	C;C,T;A	76;76,1;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	894	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1540	43.6	1	SNP	p	P64L	0	.	.	190	192	CCA	540	542	CCA	78;79;80	C;C,T;A	76;76,1;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	894	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1540	43.6	1	SNP	p	P64S	0	.	.	190	192	CCA	540	542	CCA	78;79;80	C;C,T;A	76;76,1;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	548	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1264	32.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	L46P	NONSYN	136	138	CTG	3	5	CCG	1;1;2	C;C;G	1;1;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	27	29	GAT	2;2;2	G;A;T	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	129	131	ATG	4;4;4	A;T;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	132	134	CCG	4;4;4	C;C;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	165	167	GAA	8;8;7	G;A;A	8;8;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	168	170	TCC	7;7;7	T;C;C	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	171	173	GGG	7;7;8	G;G;G	7;7;8	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	195	197	AAT	8;8;8	A;A;T	8;8;8	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	200	gadW	729	596	94.13	gadW.l15.c30.ctg.1	766	19.6	0	.	p	.	0	S234A	NONSYN	700	702	TCG	567	569	GCG	25;25;25	G;C;G	25;25;25	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	564	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1350	31.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	413	415	TTA	34;34;34	T;T;A	34;33;32	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	564	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1350	31.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	491	493	ATT	53;53;53	A;T;T	51;53;53	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	564	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1350	31.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	992	994	GGA	35;34;35	G;G;A	33;32;33	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	564	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1350	31.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	998	1000	CCG	31;33;38	C;C;G	31;33;38	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2326	2328	GAA	72;71;71	G;A;A	70;71;70	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	S83L	0	.	.	247	249	TCG	541	543	TCG	84;83;82	T;C;G	84;81;82	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	S83I	0	.	.	247	249	TCG	541	543	TCG	84;83;82	T;C;G	84;81;82	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	S83W	0	.	.	247	249	TCG	541	543	TCG	84;83;82	T;C;G	84;81;82	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	D87H	0	.	.	259	261	GAC	553	555	GAC	79;81;82	G;A;C	77;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	D87G	0	.	.	259	261	GAC	553	555	GAC	79;81;82	G;A;C	77;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	553	555	GAC	79;81;82	G;A;C	77;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	D87N	0	.	.	259	261	GAC	553	555	GAC	79;81;82	G;A;C	77;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2664	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3221	62.2	1	SNP	p	D87V	0	.	.	259	261	GAC	553	555	GAC	79;81;82	G;A;C	77;78;81	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136I	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136G	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136S	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136E	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136L	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136C	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2438	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	3159	58.0	1	SNP	p	R136H	0	.	.	406	408	CGC	743	745	CGC	76;75;73	C;G;C	75;75;73	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	470	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1186	29.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	464	466	CCG	45;45;44	C;C;G	45;45;44	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	470	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	1186	29.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	617	619	GCC	36;36;34	G;C;C	34;35;33	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1030	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1476	52.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	204	206	TCA	52;53;54	T;C,G;A	51;51,1;53	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	394	marA	384	384	99.74	marA.l15.c4.ctg.1	939	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	608	610	AGC	27;27;28	A;G;C	25;26;28	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	710	712	CAT	21;20;20	C;A;T	21;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	V45E	0	.	.	133	135	GTG	434	436	GTG	43;43;43	G;T;G	42;41;42	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	I49S	0	.	.	145	147	ATC	446	448	ATC	43;43;43	A;T;C	42;42;42	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	A70T	0	.	.	208	210	GCA	509	511	GCA	44;44;44	G;C;A	44;43;44	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R73S	0	.	.	217	219	CGT	518	520	CGT	43;43;43	C;G;T	43;43;43	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R73C	0	.	.	217	219	CGT	518	520	CGT	43;43;43	C;G;T	43;43;43	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R77C	0	.	.	229	231	CGC	530	532	CGC	41;41;41	C;G;C	41;41;41	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R77L	0	.	.	229	231	CGC	530	532	CGC	41;41;41	C;G;C	41;41;41	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	L78M	0	.	.	232	234	CTG	533	535	CTG	41;39;39	C;T;G	41;39;39	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R94S	0	.	.	280	282	CGC	581	583	CGC	28;24;25	C;G;C	27;23;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	R94H	0	.	.	280	282	CGC	581	583	CGC	28;24;25	C;G;C	27;23;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	286	marR	435	435	97.7	marR.l15.c4.ctg.1	916	23.2	1	SNP	p	V96E	0	.	.	286	288	GTA	587	589	GTA	25;26;26	G;T;A	24;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	376	378	TTC	37;37;37	T;T;C	36;36;36	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	463	465	ATC	21;21;21	A;T;C	21;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	481	483	GCC	21;21;20	G;C;C	21;21;19	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	484	486	GTG	22;21;21	G;T;G	20;20;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	511	513	GAT	28;27;27	G;A;T	26;26;27	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	532	534	ACC	31;31;31	A,G;C;C	29,1;31;30	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	559	561	TTA	29;27;27	T;T;A	29;27;27	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	700	702	CAG	52;53;52	C;A;G	51;53;52	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	739	741	GCC	55;56;57	G;C;C	55;56;56	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	844	846	GCG	56;57;58	G;C;G	55;54;57	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	1048	1050	GTT	43;43;44	G;T;T	40;40;42	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	886	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1822	36.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1210	1210	C	56	C	56	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	782	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1772	33.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	223	223	G	21	G	21	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	782	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1772	33.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	280	282	CAG	24;24;23	C;A;G	24;24;23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	782	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1772	33.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	430	432	ATC	17;16;16	A;T;C	17;16;16	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	782	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1772	33.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	478	480	ATG	23;25;25	A;T;G	23;25;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	782	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1772	33.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	571	573	ACC	41;41;40	A;C;C	39;40;40	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2032	2034	ACC	94;93;88	A;C;C	92;92;87	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2425	2427	CAA	54;56;58	C;A;A	53;56;56	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2593	2595	ATT	43;43;43	A;T;T	43;43;42	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2677	2679	GTT	63;62;63	G;T;T	63;61;63	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2785	2787	GAG	57;59;55	G;A;G	56;54;54	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3013	3015	ATG	36;36;37	A;T;G	36;36;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2734	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3587	57.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3148	3150	GAT	57;58;58	G;A;T	56;58;53	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2574	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3679	52.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	452	454	ATG	36;36;36	A;T;G	33;33;32	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2574	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3679	52.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	938	940	ATC	58;57;56	A;T;C	57;57;56	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2574	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3679	52.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3254	3256	CAC	29;28;28	C;A;C,G	28;27;27,1	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1326	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2022	49.2	0	.	p	.	0	D3E	NONSYN	7	9	GAT	221	223	GAA	37;39;40	G;A;A	36;38;39	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1326	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2022	49.2	0	.	p	.	0	T226A	NONSYN	676	678	ACG	890	892	GCG	56;57;59	G;C;G	53;57;58	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1326	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2022	49.2	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1232	1234	ATC	59;60;62	A;T;C	56;58;59	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1326	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	2022	49.2	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1535	1537	TTT	80;81;82	T;T;T	77;79;80	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1292	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1691	57.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3214	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3674	65.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1180	1182	ACC	62;63;63	A;C;C	62;63;63	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3214	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3674	65.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2422	2424	GAC	76;74;74	G;A;C	76;73;74	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1124	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1630	43.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	663	665	ATC	66;67;67	A;T;C	66;67;67	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1124	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	588	21.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	154	156	GGA	15;17;18	G;G;A	15;17;18	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1098	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1746	47.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	712	714	TGT	61;65;65	T;G;T	61;65;65	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1098	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1746	47.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1282	1284	TTG	68;68;66	T;T;G	66;68;66	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1098	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1746	47.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1492	1494	ACG	25;25;23	A;C;G	24;25;23	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1352	mdtL	1176	1176	98.21	mdtL.l6.c4.ctg.1	1810	55.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	927	929	TCC	44;44;46	T;C;C	40;44;45	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	906	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1579	42.9	0	.	p	.	0	V119I	NONSYN	355	357	GTT	619	621	ATT	56;56;55	A;T;T	55;56;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	298	300	ATG	46;47;47	A;T;G	45;45;46	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	364	366	ATC	32;32;35	A;T;C	32;32;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	613	615	CGC	56;54;56	C;G;C	56;54;56	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	979	981	AGC	64;64;65	A;G;C	63;61;64	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1180	1182	GTG	50;51;51	G;T;G,C	50;49;49,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1243	1245	AAC	35;35;37	A;A,C;C	27;25,4;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1288	1290	GTC	38;38;38	G;T;C	38;36;38	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1318	1320	ATA	44;44;44	A;T;A	44;43;43	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1426	1428	TCT	59;58;59	T;C;T	59;58;59	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1813	1815	GCG	54;56;58	G;C;G	53;56;57	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1914	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2654	54.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2026	2028	ATC	78;79;78	A;T;C	77;78;78	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	513	513	T	79	T	76	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	S129A	NONSYN	385	387	TCA	696	698	GCG	54;55;56	G;C;G	53;54;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	A187T	NONSYN	559	561	GCC	870	872	ACC	61;61;61	A;C;C	57;60;59	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	H211R	NONSYN	631	633	CAC	942	944	CGC	58;58;58	C;G;C	58;58;58	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1059	1061	GCT	47;47;48	G;C;T	44;47;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1143	1145	AAA	29;29;28	A;A;A	29;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1161	1163	CGA	28;31;34	C;G;A	28;31;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1326	1328	GCC	42;41;43	G;C;C	42;41;42	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1338	1340	GAT	44;44;46	G;A;T	44;42;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1078	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1997	40.5	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1755	1757	GCT	30;30;30	G;C;T	29;30;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3176	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3958	60.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1590	1592	AAG	45;44;44	A;A;G	45;44;44	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3176	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3958	60.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2667	2669	CTG	55;54;55	C;T;G	55;52;53	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	332	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	893	28.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1830	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2378	57.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1150	1152	AAC	68;67;67	A;A;C	68;66;67	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1830	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2378	57.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1696	1698	ATA	90;90;89	A;T;A	90;88;88	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1414	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1772	60.3	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1345	1347	GAT	91;91;90	G;A;T	89;88;88	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1414	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1772	60.3	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1348	1350	CTG	92;94;97	C;T;G	91;93;94	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	393	395	TGT	68;71;71	T;G;T	67;70;70	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	663	665	ACC	48;49;49	A;C;C	48;49;48	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	873	875	GAC	67;68;65	G;A;C	67;67;65	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	1	SNP	p	R15C	0	.	.	43	45	CGC	357	359	CGC	58;55;57	C;G;C	57;54;56	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	1	SNP	p	S33R	0	.	.	97	99	AGC	411	413	AGC	73;73;73	A;G,C;C	73;72,1;72	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	1	SNP	p	G131D	0	.	.	391	393	GGC	705	707	GGC	46;46;47	G;G;C	46;46;46	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	1	SNP	p	R203C	0	.	.	607	609	CGT	921	923	CGT	69;70;69	C;G;T	69;70;69	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	668	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1271	39.6	1	SNP	p	R203L	0	.	.	607	609	CGT	921	923	CGT	69;70;69	C;G;T	69;70;69	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1436	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1690	63.9	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1205	1207	GAG	85;86;86	G;A;G	83;84;84	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1436	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1690	63.9	1	SNP	p	G141D	0	.	.	421	423	GGT	692	694	GGT	106;104;106	G;G;T	105;104;105	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1436	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1690	63.9	1	SNP	p	G141E	0	.	.	421	423	GGT	692	694	GGT	106;104;106	G;G;T	105;104;105	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1436	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1690	63.9	1	SNP	p	R154A	0	.	.	460	462	CGT	731	733	CGT	94;94;96	C;G;T	93;93;94	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1436	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1690	63.9	1	SNP	p	R154D	0	.	.	460	462	CGT	731	733	CGT	94;94;96	C;G;T	93;93;94	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.29	parC_2.l6.c17.ctg.1	2885	59.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1896	1898	TCG	76;78;80	T;C;G	76;77;80	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.29	parC_2.l6.c17.ctg.1	2885	59.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2511	2513	AAC	58;57;57	A;A;C	57;56;55	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.29	parC_2.l6.c17.ctg.1	2885	59.1	1	SNP	p	A85T	0	.	.	253	255	GCG	525	527	GCG	73;74;72	G;C,A;G	73;73,1;72	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.29	parC_2.l6.c17.ctg.1	2885	59.1	1	SNP	p	D111H	0	.	.	331	333	GAT	603	605	GAT	69;72;71	G;A;T	69;72;71	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2284	parC_2	2259	2259	99.29	parC_2.l6.c17.ctg.1	2885	59.1	1	SNP	p	S129P	0	.	.	385	387	TCC	657	659	TCC	67;69;67	T;C;C	67;66;66	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	1704	parE_1	1893	1893	97.57	parE_1.l15.c4.ctg.1	2647	48.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1747	1749	GAT	93;94;94	G;A;T	91;90;90	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1298	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2098	46.6	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1435	1437	GAT	57;57;57	G;A;T	57;55;57	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1298	patA	1380	1380	99.78	patA.l15.c30.ctg.1	2098	46.6	0	.	p	.	0	T432I	NONSYN	1294	1296	ACA	1651	1653	ATA	58;60;61	A;T;A	58;60;61	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	V146F	0	.	.	436	438	GTT	679	681	GTT	85;83;82	G;T;T	85;82;82	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1780	1782	CAG	80;79;81	C;A,G;G	79;78,1;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1780	1782	CAG	80;79;81	C;A,G;G	79;78,1;78	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1819	1821	CAC	81;83;81	C;A;C	80;82;79	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1828	1830	CGT	78;77;77	C;G;T	78;77;77	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1828	1830	CGT	78;77;77	C;G;T	78;77;77	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1834	1836	TCC	74;73;73	T;C;C	74;73;73	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1840	1842	CTC	69;69;67	C;T;C	69;69;67	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1930	1932	ACC	71;71;71	A;C;C	70;70;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1933	1935	CCT	72;71;71	C;C;T	72;71;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4314	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4546	71.5	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2302	2304	CGT	116;117;120	C;G;T	114;115;117	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	.	n	.	0	A226G	SNP	226	226	A	334	334	G	663	G	657	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	1	SNP	n	A794T	0	.	.	794	794	A	902	902	A	617	A,G	593,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	1	SNP	n	A794G	0	.	.	794	794	A	902	902	A	617	A,G	593,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	1	SNP	n	G926A	0	.	.	926	926	G	1034	1034	G	404	G	398	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	1	SNP	n	G926T	0	.	.	926	926	G	1034	1034	G	404	G	398	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	1	SNP	n	G926C	0	.	.	926	926	G	1034	1034	G	404	G	398	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	C183T,A	.	183	183	C	291	291	C	626	C,T,A	404,215,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	A250T,G	.	250	250	A	358	358	A	598	A,T,G	423,162,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	T90C	.	90	90	T	198	198	T	626	T,C	435,178	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	G474A	.	474	474	G	582	582	G	592	G,A	460,123	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	A253T,G	.	253	253	A	361	361	A	587	A,T,G	406,160,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	C194T	.	194	194	C	302	302	C	653	C,T	496,144	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	C719T,A	.	719	719	C	827	827	C	591	C,T,A	322,260,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	A79G	.	79	79	A	187	187	A	595	A,G	419,165	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.1	1109	565.4	0	HET	.	.	.	T273A,C	.	273	273	T	381	381	T	575	T,A,C	406,156,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	541	583.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	417	A,G	410,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	541	583.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	417	A,G	410,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.2	541	583.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	417	A,G	410,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	G1002A	SNP	1002	1002	G	71	71	A	184	A	179	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	G1006C	SNP	1006	1006	G	75	75	C	182	C	176	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	T1010C	SNP	1010	1010	T	79	79	C	179	C	175	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	A1019.	DEL	1019	1019	A	87	87	G	176	G	173	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	.1023G	INS	1023	1023	T	92	92	G	176	G	174	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	176	96.05	rrsB+.l15.c17.ctg.4	176	118.4	0	.	n	.	0	C1038T	SNP	1038	1038	C	107	107	T	161	T	159	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	14342	rrsB+	1542	186	100.0	rrsB+.l15.c17.ctg.5	186	209.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	702	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1087	48.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	858	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1057	60.5	1	SNP	p	R20H	0	.	.	58	60	CGC	346	348	CGC	121;117;117	C;G;C	121;117;117	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	858	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1057	60.5	1	SNP	p	G121D	0	.	.	361	363	GGT	649	651	GGT	72;73;71	G,T;G;T	70,1;72;69	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	438	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	1214	27.0	1	SNP	p	A12S	0	.	.	34	36	GCA	578	580	GCA	92;96;97	G;C;A	92;96;97	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	4290	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1341	239.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	155	4096	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1455	210.6	0	HET	.	.	.	G139A	.	139	139	G	479	479	G	305	G,A	259,40	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	3136	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1569	149.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul2;Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	950	tet-	1206	1206	99.92	tet-.l15.c17.ctg.1	1842	38.7	0	.	p	.	0	T171A	NONSYN	511	513	ACT	824	826	GCT	40;40;39	G;C;T	40;40;39	.	tetA;TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	5226	tetA	1200	1200	100.0	tetA.l15.c30.ctg.1	1632	232.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	384	tetC	594	594	99.66	tetC.l15.c17.ctg.1	1172	24.7	0	.	p	.	0	S152D	NONSYN	454	456	AGT	688	690	GAT	33;33;33	G;A;T	33;33;33	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	422	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	913	33.3	1	SNP	p	H64Y	0	.	.	190	192	CAC	347	349	CAC	43;43;44	C;A;C	41;41;42	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	422	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	913	33.3	1	SNP	p	N82H	0	.	.	244	246	AAT	401	403	AAT	40;40;39	A;A;T	40;40;39	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	422	tetR_1	624	624	100.0	tetR_1.l15.c17.ctg.1	913	33.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	3072	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1153	199.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1692	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2201	57.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
